[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ValueForAll1 value

value posts on X about $cdxs, $lly, $prqr, $alny the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

• X Week XXXXX +453%
• X Month XXXXX -XX%
• X Months XXXXXX -XX%
• X Year XXXXXXX +155%

Mentions: X #

• X Week X -XX%
• X Month X -XX%
• X Months XX -XX%
• X Year XXX +103%

Followers: XXX #

• X Week XXX +1.90%
• X Month XXX +0.67%
• X Months XXX +21%
• X Year XXX -XXXX%

CreatorRank: XXXXXXXXX #

Social Influence #

---

Social category influence stocks XXXXX% countries XXXX% exchanges XXXX%

Social topic influence $cdxs #1, $lly #63, $prqr #3, $alny 3.03%, $nvs 3.03%, china 3.03%, india 3.03%, countries 3.03%, $wve 3.03%, $arwr XXXX%

Top accounts mentioned or mentioned by @biochemyst1 @jfais20 @biohazard3737 @richtrades100 @pikacapital @bigpharmaguy @sanctuarybio @sagimet @krtlarson @immunitybio @beonemedicines @iovancebio @bristolmyers @jazzpharma @servierpharma @genetech @shikhajainmd @dredkim @oneiltrader @pooterheadpharm

Top assets mentioned Eli Lilly and Company (LLY) Alnylam Pharmaceuticals, Inc. (ALNY) Novartis AG (NVS) Arrowhead Research Corporation (ARWR) Bristol-Myers Squibb Co (BMY) GSK plc (GSK) AbbVie Inc (ABBV)

Top Social Posts #

---

Top posts by engagements in the last XX hours

"As of today the vast majority of building blocks (NQP) for siRNA drugs of e.g. $alny and $nvs is manufactured using hash chemicals with a lot of toxic waste primary in China and India. There should be a better way rooting for $cdxs"
X Link @ValueForAll1 2025-09-27T23:50Z XXX followers, XXX engagements

"@biochemyst1 The more they wait the less cash the less cash the more leverage Lilly has"
X Link @ValueForAll1 2025-10-12T15:21Z XXX followers, XX engagements

"Some countries are way easier to get novel modality Phase X clinical trial approval for. E.g. $wve runs INHBE obesity trial in Moldova $arwr in New Zealand. $prqr naively applied in Netherlands and now in the dark"
X Link @ValueForAll1 2025-10-12T13:49Z XXX followers, 1675 engagements

"If $bmy picks up preclinical Orbital for $1.5B in cash I don't see why $lly has to pay less for $prqr. Novel modalities should be valued appropriately"
X Link @ValueForAll1 2025-10-11T15:46Z XXX followers, XXX engagements

"$scyx was on their way to restore their minimum bid NASDAQ compliance but on Sep XX someone stopped that XX days restarted and today it was stopped by nonsense "sell the news". Execs are very naive here. Bought the dip. $gsk should just end this suffering with low-ball BO"
X Link @ValueForAll1 2025-09-30T17:15Z XXX followers, XXX engagements

"$lly: Sr. Principal Process Engineer - Oligonucleotides Lilly plans to build a new $XXX billion facility to manufacture active pharmaceutical ingredients in Texas $cdxs $bchmf"
X Link @ValueForAll1 2025-10-11T20:27Z XXX followers, XXX engagements

"$irwd Very likely it's the last month below $X. ACG presentations Abbvie Q3 earnings. Maybe something bigger"
X Link @ValueForAll1 2025-10-08T21:41Z XXX followers, XXX engagements

"$cdxs Finally waking up a bit. TIDES EU is in a month this webinar with Bachem looks interesting. Bachem is a one stop to $lly who are betting a lot on oligos for the upcoming decade"
X Link @ValueForAll1 2025-10-07T03:49Z XXX followers, 1097 engagements